Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126088461 | 12608846 | 1 | I | 201601 | 20160719 | 20160730 | 20160730 | PER | US-ASTRAZENECA-2016SE78382 | ASTRAZENECA | 712.00 | MON | F | Y | 62.60000 | KG | 20160730 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126088461 | 12608846 | 1 | PS | ZOMIG | ZOLMITRIPTAN | 1 | Oral | U | 20768 | TABLET | |||||||||
126088461 | 12608846 | 2 | SS | RELPAX | ELETRIPTAN HYDROBROMIDE | 1 | Unknown | 40.0MG AS REQUIRED | 0 | 40 | MG | TABLET | |||||||
126088461 | 12608846 | 3 | C | NORTRIPTYLINE | NORTRIPTYLINE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126088461 | 12608846 | 1 | Migraine |
126088461 | 12608846 | 2 | Migraine |
126088461 | 12608846 | 3 | Migraine |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126088461 | 12608846 | Drug dose omission | |
126088461 | 12608846 | Drug ineffective | |
126088461 | 12608846 | Migraine |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |